Penile rehabilitation effectiveness after prostate cancer treatment: A systematic review of randomized controlled trials

Authors

  • Roshan Prasad Department of Internal Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India https://orcid.org/0000-0002-1958-2026
  • Mayur Wanjari Department of Research and Development, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India https://orcid.org/0000-0001-7794-2408
  • Yeshwant R. Lamture Department of Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India
  • Sampada Late Government Hospital Samudrapur, Maharashtra, India
  • Ranjana Sharma Department of Medical Surgical Nursing, Smt. Radhikabai Meghe Memorial College of Nursing, Datta Meghe Institute of Higher Education and Research, Wardha, India https://orcid.org/0000-0002-0009-9114

DOI:

https://doi.org/10.52225/narra.v3i2.174

Keywords:

Prostate cancer, penile rehabilitation, erectile dysfunction, randomized controlled trial, PDE5 inhibitor

Abstract

Prostate cancer treatment can significantly impact erectile function, and penile rehabilitation has been proposed to improve the impacts. However, the effectiveness of penile rehabilitations after treatment of prostate cancer is scarce. The aim of this systematic review was to evaluate the effectiveness of different interventions of penile rehabilitation program after prostate cancer treatment. We conducted a comprehensive search of electronic databases, PubMed and Google Scholar, to identify randomized controlled trials that evaluated interventions for penile rehabilitation after prostate cancer treatment. Studies that met our inclusion criteria were systematically reviewed, and data were synthesized and analyzed. We identified 11 randomized controlled trials that evaluated different interventions for penile rehabilitation after prostate cancer treatment. The interventions included the use of phosphodiesterase type 5 inhibitors, intracavernous injections, vacuum erection devices, and penile rehabilitation programs. The data suggest that these phosphodiesterase inhibitors, intracavernous injections, vacuum erection devices, and penile rehabilitation programs are promising in improving erectile function after prostate cancer treatment. However, the optimal timing and duration of these interventions remain unclear, and there is a need for further research to determine their long-term effectiveness and safety. Healthcare providers should consider individualized approaches to penile rehabilitation, taking into account patient characteristics and preferences.

Downloads

Download data is not yet available.

Downloads

Issue

Section

Original Article

Citations